We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+6.23%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$7.83B
AUM Growth
+$242M
Cap. Flow
+$66M
Cap. Flow %
0.84%
Top 10 Hldgs %
24.31%
Holding
167
New
14
Increased
53
Reduced
26
Closed
21

Top Buys

Rank Stock Value
1
DLO icon
dLocal
DLO
+$168M
2
GLBE icon
Global E Online
GLBE
+$100M
3
GH icon
Guardant Health
GH
+$73.2M
4
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
+$67.7M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$39.4M

Top Sells

Rank Stock Value
1
FVRR icon
Fiverr
FVRR
+$127M
2
TWLO icon
Twilio
TWLO
+$126M
3
TRIL
Trillium Therapeutics Inc.
TRIL
+$91.8M
4
TTD icon
Trade Desk
TTD
+$49.7M
5
ALLK
Allakos
ALLK
+$44.2M

Sector Composition

Rank Sector Weight
1 Healthcare 33.78%
2 Technology 28.4%
3 Industrials 14.84%
4 Consumer Discretionary 8.57%
5 Communication Services 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLL icon
51
Collegium Pharmaceutical
COLL
$1.17B
$49.1M 0.63%
2,629,593
– –
XMTR icon
52
Xometry
XMTR
$4.69B
$48.9M 0.62%
954,030
+211,228
+28% +$10.9M
VRSK icon
53
Verisk Analytics
VRSK
$26.1B
$48.7M 0.62%
213,000
– –
CLDX icon
54
Celldex Therapeutics
CLDX
$3.02B
$47.9M 0.61%
1,238,900
+110,900
+10% +$4.83M
MDB icon
55
MongoDB
MDB
$26.2B
$47.3M 0.6%
89,355
– –
EPIX
56
DELISTED
ESSA Pharma
EPIX
$47.1M 0.6%
3,318,647
+1,137,546
+52% +$12.7M
ZYME icon
57
Zymeworks
ZYME
$1.67B
$46.2M 0.59%
2,819,135
-910,054
-24% -$19M
DICE
58
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$45.8M 0.58%
1,871,612
– –
SHLS icon
59
Shoals Technologies Group
SHLS
$1.49B
$44.9M 0.57%
1,846,900
-58,160
-3% -$1.67M
ZNTL icon
60
Zentalis Pharmaceuticals
ZNTL
$350M
$44.5M 0.57%
529,000
– –
BEP icon
61
Brookfield Renewable
BEP
$9.9B
$44.2M 0.57%
1,236,000
– –
MRTX
62
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$42.8M 0.55%
291,626
+162,155
+125% +$25.2M
COUR icon
63
Coursera
COUR
$1.51B
$42.5M 0.54%
1,738,228
+938,228
+117% +$28.5M
BPMC
64
DELISTED
Blueprint Medicines
BPMC
$42.4M 0.54%
395,800
+39,800
+11% +$4.16M
IMVT icon
65
Immunovant
IMVT
$8.11B
$42.2M 0.54%
4,950,000
– –
MPWR icon
66
Monolithic Power Systems
MPWR
$64.7B
$42M 0.54%
85,157
+7,698
+10% +$3.97M
STRO icon
67
Sutro Biopharma
STRO
$411M
$40.3M 0.52%
270,898
+33,800
+14% +$6.06M
ADCT icon
68
ADC Therapeutics
ADCT
$141M
$39.9M 0.51%
1,975,000
+663,010
+51% +$16M
CCXI
69
DELISTED
ChemoCentryx, Inc.
CCXI
$37.9M 0.48%
1,040,000
– –
NCNO icon
70
nCino
NCNO
$2.01B
$37.7M 0.48%
688,000
+25,500
+4% +$1.66M
MASS icon
71
908 Devices
MASS
$313M
$36.5M 0.47%
1,410,000
+727,729
+107% +$21.4M
LSCC icon
72
Lattice Semiconductor
LSCC
$17.7B
$36.4M 0.46%
471,744
+413,297
+707% +$30.7M
ANNX icon
73
Annexon
ANNX
$863M
$32.7M 0.42%
2,850,000
+318,372
+13% +$5.14M
NVT icon
74
nVent Electric
NVT
$23.4B
$31.6M 0.4%
832,200
+60,200
+8% +$2.14M
RGEN icon
75
Repligen
RGEN
$7.03B
$31.5M 0.4%
119,000
– –
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Eventide Asset Management held 167 positions worth $7.83B, up 3.2% from $7.58B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q4 2021 filing shows 14 new, 53 increased, 26 reduced and 21 closed positions. Its largest new stake was KnowBe4, Inc. Class A Common Stock: 2,886,000 shares worth $66.2M. The largest sale was Fiverr, an estimated $127M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 34% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q4 2021 buy was KnowBe4, Inc. Class A Common Stock: 2,886,000 shares worth $66.2M.
  • Eventide Asset Management added most to dLocal in Q4 2021, an estimated $168M increase.
  • Eventide Asset Management's biggest Q4 2021 reduction was Trade Desk, cutting an estimated $49.7M.
  • Eventide Asset Management fully exited Fiverr in Q4 2021, selling an estimated $127M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.83B portfolio in Q4 2021.
  • Eventide Asset Management opened 14 new positions and closed 21 in Q4 2021.
  • Eventide Asset Management's portfolio value rose 3.2% quarter-over-quarter to $7.83B.

Based on Eventide Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.